International Cannabis Weekly: 177

THE MORE ACT PASSES THROUGH US HOUSE OF REPRESENTATIVES

The MORE Act, which would decriminalise cannabis federally, passed through the democrat-led House of Representatives last week, with 228 votes for the motion, 164 against & 39 abstaining.

The bill will now face a vote in the Senate before being presented to the President for ratification.

LEARN MORE

• US House of Representatives passes medical cannabis bill following MORE Act approval.
• The Netherlands selects 10 cultivators for legal cannabis experiment.

• UK experts and lawmakers eye cannabis legalisation amid COVID-19 crisis.
• North Macedonian cannabis advocates urge parliament to amend cannabis classification.
• Clever Leaves successfully delivers EU-GMP cannabis-based pharmaceuticals to Germany.
• LYPHE Group partners with Drug Science to provide medical cannabis to Project Twenty21.
• Switzerland’s National Council votes to ease access for medical cannabis.
• Slovakian government approves amendment to remove CBD from drug list.
• Maltese cannabis advocates call for full decriminalisation of cannabis cultivation by 2021.

LINKS BETWEEN COVID-19 AND CANNABINOID DRUG DEVELOPMENT EXPLORED

During Prohibition Partners LIVE, Industry Analyst & Consultant for Prohibition Partners Conor O’Brien, delivered a presentation on the research being carried out on cannabinoids and their impact on treating COVID-19.

The full presentation is available to view, here.

WATCH NOW

• New report suggests federal legalisation would generate US$13.7 billion in tax revenue.
• Medical cannabis sales in Maine reach US$221.8 million from January to October 2020.
• New Jersey lawmakers agree on adult-use cannabis legalisation bill.
• Detroit plans to issue adult-use cannabis licences in summer 2021.
• The Justice Department and the Department of Health examine rescheduling of cannabis.
• New poll finds two thirds of voters support House vote to decriminalise cannabis.
• Weedmaps plans to list on the NASDAQ through merger with Silver Spike.
• Nebraska lawmakers commence drafting cannabis legalisation initiative for 2022 ballot.
• New poll finds 54 per cent of Wyoming residents support legalising adult-use cannabis.

• Canopy Growth management continues to underperform as it cuts 220 jobs.
• Ontario’s cannabis store regulator increases the pace of store authorisations.
• Aphria closes acquisition of SweetWater Brewing Company.
• Canadian cannabis retailer, High Tide, announces application to list on NASDAQ.

• Mexican Supreme Court extends deadline for lawmakers to legalise cannabis to April 2021.
• Avicanna launches medical cannabis programme nationwide in Colombia.
• Costa Rican lawmakers seek to legalise medical cannabis.
• Khiron successfully imports high-THC medical cannabis products into Peru.
• Brazil makes slow progress on medical cannabis cultivation legalisation bill.
• Khiron’s medical cannabis products qualify for national insurance coverage in Colombia.

• iX Biopharma receives Australian CBD product of the year award.
• Australian Natural Therapeutics receives medicinal cannabis oil manufacturing licence.
• New Zealand pharmacies accused of overcharging patients for medical cannabis.
• Three out of five prescriptions for medical cannabis are to treat chronic pain in Australia.
• CannaPacific and CSIRO trial novel encapsulation technologies for medicinal cannabinoids.
• New Zealand farmers prepare to export ‘world’s best’ medical cannabis.
• Thailand is set to launch Southeast Asia’s first-ever cannabis tour.

• Panaxia receives its first commercial export permit for medical cannabis products.
• Israel’s Health Committee expects to exclude CBD from the Drug Ordinance.
• Charlotte’s Web announces expansion into Israel through InterCure distribution agreement.
• Middle East law firm launches region’s first dedicated medical cannabis practice.
• Aleafia Health signs three-year agreement with Equinox International to enter Israeli market.
• British entrepreneur assists in the utilisation of high-quality cannabis in Malawi.